RACHAEL SMITH: Open Payments
NPI 1750938643 · MEMPHIS, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$771 in 23 payments from 8 companies in 2025. Trend: 2023 $181 · 2024 $643 · 2025 $771
Food & beverage: $771
| Company | Payments | Amount |
|---|---|---|
| Kowa Pharmaceuticals America, Inc. | 5 | $157 |
| AstraZeneca Pharmaceuticals LP | 2 | $155 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $141 |
| Novo Nordisk Inc | 1 | $117 |
| GlaxoSmithKline, LLC. | 3 | $76 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $65 |
| ABBVIE INC. | 2 | $41 |
| Neurocrine BioSciences, Inc. | 1 | $20 |
Products named: ZORYVE, JARDIANCE, BREZTRI, Ozempic, Kerendia, TRELEGY ELLIPTA, FARXIGA, UBRELVY.
Industry payments across TN — which companies pay providers there.
